11/8/2022NMPA Solicits Comments on the Technical Guidelines for Clinical Resear...

11/8/2022CDE Issues the Technical Guidelines for Alcohol Dose Dumping Tests in ...

11/8/2022CDE Issues on the Q&As on Research Conditions of Dissolution Curve in ...

11/8/2022CDE Solicits Comments on the Technical Guidelines for New Drug Benefit...

11/8/2022HEC Barred from Selling Linagliptin Products following Patent Ruling (...

11/7/2022Trends and Characteristics of New Drug Approvals in China, 2011–2021

11/7/2022NMPA Solicits Comments on Documents Relating To e-Submission of Drug R...

11/6/2022CBC to Build a $137 Million Biopharma Complex in Western Shanghai

11/6/2022Eucure Inks Partnership with ISU ABXIS To Develop Tri-Specific Antibod...

11/6/2022China to Approve BioNTech's Covid-19 Vaccine for Foreigners with Pathw...

11/6/2022Germany Pharma CEOs Visit China with German Chancellor Scholz

11/4/2022NMPA Announces Package Insert Revision of Methotrexate Oral Formulatio...

11/4/2022Recent Executive Moves

11/4/2022Drug R&D and Product Registration News Digest November 2022 (1)

11/4/2022China Clarifies Regulations for Online Prescription Drug Sales, But Th...

11/4/2022The Race To The Bottom In The Chinese Pharmaceutical Market Reinforces...

11/3/2022NMPA Releases the Draft List of Drugs Prohibited for Online Sales for ...

11/3/2022Global Data: Small Molecule Renaissance in Rare Diseases for China's B...

11/3/202245 Orphan Drugs Included in China's Latest National Drug Reimbursemne...

11/2/2022CDE Issues the Technical Guidelines for Design and Evaluation of Pedia...

11/2/2022NMPA Announces Package Insert Revision of Liver Hydrolyzed Peptide Inj...

11/1/2022NMPA Initiates New Certification Documents for APIs and Drug Exports

11/1/2022TPG Capital Asia Acquires Majority Stake in iNova Pharmaceuticals

11/1/2022Pharmaniaga Partners JD.com to Enter China Healthcare Market

11/1/2022Invincible Diabetes Turns APAC Into Pharma Goldmine (BioSpectrum)

11/1/2022China Bars Celebrities from Endorsing Products to Boost 'Traditional V...

10/31/2022Yes! It's Now Time to Reconfigure Your China Business Model Again

10/31/2022Big Pharma Dominated the Deals Space in September (PharmaDJ)

10/31/2022Financial-related Company News Digest (October 2022)

10/31/2022Novartis Abandons US PD-1 Submission Plan for Tislelizumab

Page:146/798 Total number of articles:23926: [First][<<] [144] [145] [146] [147] [148] [>>] [End]